Group 1 - The report emphasizes the focus on "April Decision" under the economic context, indicating a shift from expectation-driven trading to fundamental pricing, with economic data, performance realization, and policy changes forming a "stress test" framework for stock prices [4][6][9] - The report highlights a selection of "golden stocks" across various sectors, including mechanical, electronic, environmental, coal and steel, computing, electric new energy, media internet, and pharmaceuticals, with detailed financial metrics provided for each [2][6][72] - The report suggests that the "April Decision" may lead to increased volatility in high-odds growth stocks, while larger, value-oriented stocks tend to perform better historically during this period [4][6] Group 2 - For the mechanical sector, the report recommends Niuwei Co., which is positioned as a global leader in industrial valves, benefiting from strong demand in LNG and marine industries, with expected overseas order growth of over 30% in the first half of 2024 [9][10][11] - In the electronic sector, Tianyue Advanced is highlighted for its core role in AR glasses components, with anticipated demand growth driven by major tech companies' product launches [15][16][17] - The environmental sector's Huanlan Environment is noted for its strong dividend growth and improved cash flow from debt resolution, with significant operational scale expansion through acquisitions [20][21][24] - In the coal and steel sector, Shanjin International is expected to benefit from rising gold prices amid economic stagnation risks, with a strong production outlook and low cost per gram of gold [27][29][30] - Dongtu Technology in the computing sector is recognized for its advanced operating system and AI-driven robotics, positioning it well for future growth in industrial automation [33][34][35] - Keda Li in the electric new energy sector is projected to maintain strong profit growth driven by high lithium battery demand, with a favorable valuation outlook [38][39][41] - XGIMI Technology in the media internet sector is expected to see revenue growth from domestic recovery and international expansion, particularly in the automotive sector [44][45][48] - In the pharmaceutical sector, Sanofi Pharmaceutical is noted for its solid fundamentals and multiple new product launches, contributing to revenue diversification [50][51][53] - Innovent Biologics is highlighted for its robust pipeline and international expansion potential, with several new drugs expected to drive revenue growth [55][56][61] - Zoli Pharmaceutical is recognized for its steady growth in traditional Chinese medicine products and successful new product launches, with ambitious profit targets [65][66][68]

摘要 1、今天，A股成功收红，半导体板块回暖，中药、医疗等板块涨幅居前。 2、刚刚，央行指出将根据国内外经济金融形势择机降准降息。外资集体看好，后市会怎么走？ 3、即将迎来的"四月决断"会如何演绎？复盘历史，这些板块在4月上涨概率超过80%！ 真话白话说财经，理财不说违心话 --这是第1325 篇白话财经- - 在昨晚美股大跌的背景下，A股港股走出了独立行情，集体收涨。 但是仅有不足1.2万亿的成交额让今天的A股有些"食之无味"了。 （图片来源：东方财富APP，统计截至2025/3/27，不作投资推荐） 分析人士认为，随着国内宏观调控、促增长政策持续落地推进，A股短期调整后将重拾升势，风格将进入再平衡阶段。 A股回暖，两大利好来袭！ 对于今天市场的回暖，分析人士认为，主要有两大原因。 一个，是在外围不确定性下，外资集体看好中国市场。 昨晚，特朗普宣布对所有进口汽车征收25%关税，引发美股市场回调。 分析人士认为，由于美联储缩表还在持续，全球资产现在似乎都处于一个存量博弈的状态，在美股表现出色的时候，中国资产往往相对落后，反之亦然。 而外资集体唱多中国股市，也超出了预期，让市场情绪开始回暖。 高盛在最新的报告中 ...

以下文章来源于申万宏源证券上海分公司 ，作者杨敏 申万宏源证券上海分公司 . 申万宏源证券上海分公司官微，能为您提供账户开立、软件下载、研究所及投顾资讯等综合服务，为您 的财富保驾护航。 摘要： 短期震荡还将继续，耐心等待流动性和四月决断催化的落地。 ------------------ 盘面走弱体现在三方面： 一、一直是市场情绪指标的北证50周四开始出现了趋势的破位，影响小盘股的情绪。 二、盘面近期连续的负反馈，这周科技多个发布会和财报落地，对于一些财报超预期的公司，相关板块 走势偏弱。 三、低位持续性不强，高位没有增量。 展开说，低位的顺周期品种，反弹一波修复估值后，近期涨不动了，等待宏观数据的催化。高位的科技 股，新催化有，但市场对普通的消息已经反馈递减，从deepseek到阿里财报到manus到近期的腾讯、小 米财报，对板块的拉动边际效应降低。新进的资金也不愿意在没有调整的时候直接进场买科技。 以上三个现象造成了近期市场走势的震荡，破局点在于两方面; 1、流动性 周四凌晨美联储利率决议三个要点：3月不降息以及年内有望两次降息都符合预期，但有一个超预期， 即4月1日开始放缓资产负债表缩减步伐。明显偏鸽派 ...